Login to Your Account



Other News To Note


Friday, September 20, 2013
• Argen-x BV, of Breda, the Netherlands, said it attained a milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Dublin-based Shire plc, triggering an undisclosed payment from Shire.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription